MDT

99.81

+2.3%↑

A

137.69

+0.9%↑

VEEV

218.79

+0.25%↑

HQY

84.65

+0.12%↑

NEOG

9.61

+2.67%↑

MDT

99.81

+2.3%↑

A

137.69

+0.9%↑

VEEV

218.79

+0.25%↑

HQY

84.65

+0.12%↑

NEOG

9.61

+2.67%↑

MDT

99.81

+2.3%↑

A

137.69

+0.9%↑

VEEV

218.79

+0.25%↑

HQY

84.65

+0.12%↑

NEOG

9.61

+2.67%↑

MDT

99.81

+2.3%↑

A

137.69

+0.9%↑

VEEV

218.79

+0.25%↑

HQY

84.65

+0.12%↑

NEOG

9.61

+2.67%↑

MDT

99.81

+2.3%↑

A

137.69

+0.9%↑

VEEV

218.79

+0.25%↑

HQY

84.65

+0.12%↑

NEOG

9.61

+2.67%↑

Search

ResMed Inc

Open

SectorHealthcare

257.12 0.19

Overview

Share price change

24h

Current

Min

252.37

Max

257.46

Key metrics

By Trading Economics

Income

-31M

349M

Sales

-12M

1.3B

P/E

Sector Avg

26.391

90.831

Dividend yield

0.87

Profit margin

26.096

Employees

10,600

EBITDA

-29M

503M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+14.82% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.87%

2.20%

Next Earnings

29 Jan 2026

Next Dividend date

19 Mar 2026

Next Ex Dividend date

12 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-193M

38B

Previous open

256.93

Previous close

257.12

News Sentiment

By Acuity

29%

71%

59 / 361 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

20 Jan 2026, 23:43 UTC

Market Talk

Gold Consolidates; May Face Technical Correction -- Market Talk

20 Jan 2026, 23:42 UTC

Market Talk

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20 Jan 2026, 23:41 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20 Jan 2026, 23:29 UTC

Market Talk

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20 Jan 2026, 23:26 UTC

Market Talk

Global Equities Roundup: Market Talk

20 Jan 2026, 23:26 UTC

Market Talk

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20 Jan 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20 Jan 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20 Jan 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20 Jan 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20 Jan 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20 Jan 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20 Jan 2026, 22:27 UTC

Acquisitions, Mergers, Takeovers

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20 Jan 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20 Jan 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20 Jan 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20 Jan 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20 Jan 2026, 22:18 UTC

Earnings

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20 Jan 2026, 22:17 UTC

Acquisitions, Mergers, Takeovers

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20 Jan 2026, 22:16 UTC

Acquisitions, Mergers, Takeovers

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20 Jan 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20 Jan 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20 Jan 2026, 22:13 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20 Jan 2026, 22:11 UTC

Acquisitions, Mergers, Takeovers

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20 Jan 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20 Jan 2026, 22:08 UTC

Acquisitions, Mergers, Takeovers

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20 Jan 2026, 22:07 UTC

Acquisitions, Mergers, Takeovers

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20 Jan 2026, 22:06 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20 Jan 2026, 22:00 UTC

Market Talk
Acquisitions, Mergers, Takeovers

ESG Roundup: Market Talk

20 Jan 2026, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

14.82% upside

12 Months Forecast

Average 295.75 USD  14.82%

High 345 USD

Low 260 USD

Based on 12 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

5

Hold

0

Sell

Sentiment

By Acuity

59 / 361 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat